• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: EDWARDS LIFESCIENCES EDWARDS INSPIRIS RESILIA AORTIC VALVE; TISSUE, HEART-VALVE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

EDWARDS LIFESCIENCES EDWARDS INSPIRIS RESILIA AORTIC VALVE; TISSUE, HEART-VALVE Back to Search Results
Model Number 11500A
Device Problem Inadequacy of Device Shape and/or Size (1583)
Patient Problem Laceration(s) (1946)
Event Date 04/11/2022
Event Type  Injury  
Manufacturer Narrative
Valve explant at implant is typically a result of inappropriate sizing, difficulty seating, distortion of the valve, valve displacement before or after frame expansion, and/or the patients anatomy, and not a malfunction of the device.There may be cases in which regurgitation is detected by tee prior to the completion of the surgical case and exchange of the valve is required.The device was not returned for evaluation, as it was discarded.The investigation is still in progress; therefore, a conclusion has yet to be established.A supplemental report will be submitted accordingly upon investigation completion.
 
Event Description
Edwards learned that a 23m pericardial aortic valve was explanted at implant due to oversizing.During suturing, patient annulus got torn.The device was explanted, and the torn site was repaired with a patch.The surgeon commented that the patient's annulus tear was caused by the sizing mistake.The device was replaced with a 21mm valve while the patient was on bypass with no adverse patient events reported.The patient status was reported as recovering.The device was originally implanted for aortic valve replacement to correct aortic stenosis and regurgitation.
 
Manufacturer Narrative
H10: additional narratives: updated d4, h4, and h6 per new information received.The most likely cause is procedural factors.The device history record (dhr) was reviewed and showed that this device met all manufacturing and sterilization specifications for product release prior to distribution.No issues were identified that would have impacted this event.Edwards will continue to review and monitor all events.Trends are monitored on a monthly basis and if action is required, appropriate investigation will be performed.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
EDWARDS INSPIRIS RESILIA AORTIC VALVE
Type of Device
TISSUE, HEART-VALVE
Manufacturer (Section D)
EDWARDS LIFESCIENCES
one edwards way
irvine CA 92614
Manufacturer (Section G)
EDWARDS LIFESCIENCES
one edwards way
irvine CA 92614
Manufacturer Contact
reginald santos
one edwards way
mailstop anton 6.1
irvine, CA 92614
9492502731
MDR Report Key14316896
MDR Text Key291610714
Report Number2015691-2022-05587
Device Sequence Number1
Product Code LWR
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
P150048
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Reporter Occupation Physician
Type of Report Initial,Followup
Report Date 06/13/2022
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received05/07/2022
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date08/05/2023
Device Model Number11500A
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Was the Report Sent to FDA? No
Date Manufacturer Received06/10/2022
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured08/05/2021
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention; Life Threatening; Hospitalization;
-
-